Fiessinger JN - Search Results

1

Comparison of a once daily with a twice daily subcutaneous low molecular weight heparin regimen in the treatment of deep vein thrombosis. FRAXODI group.

Charbonnier BA, Fiessinger JN, Banga JD, Wenzel E, d'Azemar P, Sagnard L. Charbonnier BA, et al. Among authors: fiessinger jn. Thromb Haemost. 1998 May;79(5):897-901. Thromb Haemost. 1998. PMID: 9609216 Clinical Trial.

2

Once-daily subcutaneous dalteparin, a low molecular weight heparin, for the initial treatment of acute deep vein thrombosis.

Fiessinger JN, Lopez-Fernandez M, Gatterer E, Granqvist S, Kher A, Olsson CG, Söderberg K. Fiessinger JN, et al. Thromb Haemost. 1996 Aug;76(2):195-9. Thromb Haemost. 1996. PMID: 8865530 Clinical Trial.

3

Adjusted versus fixed doses of the low-molecular-weight heparin fragmin in the treatment of deep vein thrombosis. Fragmin-Study Group.

Alhenc-Gelas M, Jestin-Le Guernic C, Vitoux JF, Kher A, Aiach M, Fiessinger JN. Alhenc-Gelas M, et al. Among authors: fiessinger jn. Thromb Haemost. 1994 Jun;71(6):698-702. Thromb Haemost. 1994. PMID: 7974334 Clinical Trial.

4

Heparin cofactor II: an acute phase reactant in patients with deep vein thrombosis.

Toulon P, Vitoux JF, Fiessinger JN, Sicard D, Aiach M. Toulon P, et al. Among authors: fiessinger jn. Blood Coagul Fibrinolysis. 1991 Jun;2(3):435-9. Blood Coagul Fibrinolysis. 1991. PMID: 1718466

5

Laboratory monitoring of low-molecular-weight heparin therapy.

Fiessinger JN. Fiessinger JN. J Thromb Haemost. 2004 Jun;2(6):1007. doi: 10.1111/j.1538-7836.2004.00777.x. J Thromb Haemost. 2004. PMID: 15140141 Free article. No abstract available.

6

Heparin-associated thrombocytopenia treatment with low molecular weight heparin.

Vitoux JF, Mathieu JF, Roncato M, Fiessinger JN, Aiach M. Vitoux JF, et al. Among authors: fiessinger jn. Thromb Haemost. 1986 Feb 28;55(1):37-9. Thromb Haemost. 1986. PMID: 3705006

7

Circulating activities during constant infusion of heparin or a low molecular weight derivative (enoxaparine): failure to demonstrate any circadian variations.

Toulon P, Vitoux JF, Leroy C, Lecomte T, Roncato M, Motobashi Y, Aiach M, Fiessinger JN. Toulon P, et al. Among authors: fiessinger jn. Thromb Haemost. 1987 Dec 18;58(4):1068-72. Thromb Haemost. 1987. PMID: 2832964

8

Heparin cofactor II in patients with deep venous thrombosis under heparin and oral anticoagulant therapy.

Toulon P, Vitoux JF, Capron L, Roncato M, Fiessinger JN, Aiach M. Toulon P, et al. Among authors: fiessinger jn. Thromb Res. 1988 Mar 1;49(5):497-500. doi: 10.1016/s0049-3848(98)90007-x. Thromb Res. 1988. PMID: 3376055 No abstract available.

9

Incidence and prognosis of cancer associated with bilateral venous thrombosis: a prospective study of 103 patients.

Bura A, Cailleux N, Bienvenu B, Léger P, Bissery A, Boccalon H, Fiessinger JN, Levesque H, Emmerich J. Bura A, et al. Among authors: fiessinger jn. J Thromb Haemost. 2004 Mar;2(3):441-4. doi: 10.1111/j.1538-7933.2004.00619.x. J Thromb Haemost. 2004. PMID: 15009461 Free article.

10

High total and free protein S in patients with acute deep vein thrombosis.

Toulon P, Gandrille S, Vitoux JF, Fiessinger JN, Sultan Y, Aiach M. Toulon P, et al. Among authors: fiessinger jn. Thromb Res. 1990 Jul 1;59(1):213-7. doi: 10.1016/0049-3848(90)90286-l. Thromb Res. 1990. PMID: 2144670 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

350 results

Search Page

Filters